Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Inkwood Research | PRODUCT CODE: 1142629

Cover Image

PUBLISHER: Inkwood Research | PRODUCT CODE: 1142629

Europe Epilepsy Devices Market Forecast 2022-2030

PUBLISHED:
PAGES: 157 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 1600
PDF & Excel (Corporate License)
USD 2200

Add to Cart

KEY FINDINGS

The Europe epilepsy devices market is anticipated to grow with a 7.61% CAGR during the estimated period 2022-2030. The technological advancements in therapeutic devices, the growing geriatric population prone to epilepsy, and reimbursement availability drive the Europe market growth.

MARKET INSIGHTS

The Europe epilepsy devices market growth evaluation entails an assessment of Germany, Italy, Nordic Countries, Spain, United Kingdom, France, and Rest of Europe. Geographic and socioeconomic factors may impact epilepsy prevalence. The Nordic nations are not only close geographically, but they also have a lot of similarities in their cultures, standards of living, and economy. Publicly subsidized, all-encompassing healthcare systems protect the Nordic region's whole resident population. The resultant ever-growing aging population, early detection and diagnosis of epilepsy among the population, and various medical therapies have increased the market for epilepsy devices in Nordic Countries.

In Spain, epilepsy affects more than 4,000 children annually. Refractory epilepsy, or epilepsy that does not respond to medication, affects one in three people. Drug-resistant forms of epilepsy place a heavy strain on patients and their families. With recurring crises, underlying neurological conditions, medication side effects, and societal stigmatization, patients present major medical and social problems.

As a result, epilepsy treatments involving vagus nerve stimulation, deep brain stimulation, accelerometer, and neurostimulation will gain popularity throughout the anticipated period. Spain is also aiming to develop modern healthcare systems that will make available more affordable and effective solutions for the general people, increasing demand for epilepsy equipment.

COMPETITIVE INSIGHTS

Some of the key players include: Philips NV, LivaNova PLC, NeuroPace Inc, Nihon Kohden Corporation, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation caters to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Product Code: 48681

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. SOARING OCCURRENCES OF EPILEPSY GLOBALLY
    • 3.1.2. ONSET OF EPILEPSY IN ELDERLY PEOPLE
    • 3.1.3. MITIGATION OF EPILEPSY USING EARLY DIAGNOSIS
    • 3.1.4. SURGE IN POST-TRAUMATIC EPILEPSY WITH RISING BRAIN INJURY CASES
  • 3.2. KEY RESTRAINTS
    • 3.2.1. MISPERCEPTIONS AND MISINFORMATION ABOUT EPILEPSY
    • 3.2.2. SHORTAGE OF NEUROLOGY SPECIALISTS IN THE HEALTHCARE SYSTEM

4. KEY ANALYTICS

  • 4.1. IMPACT OF COVID-19 ON EPILEPSY DEVICES MARKET
  • 4.2. KEY MARKET TRENDS
  • 4.3. PORTER'S FIVE FORCES ANALYSIS
    • 4.3.1. BUYERS POWER
    • 4.3.2. SUPPLIERS POWER
    • 4.3.3. SUBSTITUTION
    • 4.3.4. NEW ENTRANTS
    • 4.3.5. INDUSTRY RIVALRY
  • 4.4. OPPORTUNITY MATRIX
  • 4.5. VENDOR LANDSCAPE
  • 4.6. VALUE CHAIN ANALYSIS
  • 4.7. KEY BUYING CRITERIA
    • 4.7.1. COMFORT & USABILITY
    • 4.7.2. PRODUCT FEATURES
    • 4.7.3. CONFIDENTIALITY
  • 4.8. REGULATORY FRAMEWORK

5. MARKET BY PRODUCT TYPE

  • 5.1. CONVENTIONAL DEVICES
  • 5.2. WEARABLE DEVICES
    • 5.2.1. WATCHES
    • 5.2.2. BRACELETS
    • 5.2.3. CAMERA DEVICES
    • 5.2.4. MATTRESS DEVICES
    • 5.2.5. ANTI-SUFFOCATION PILLOWS
    • 5.2.6. OTHER WEARABLE DEVICES
  • 5.3. IMPLANTABLE DEVICES

6. MARKET BY TECHNOLOGY

  • 6.1. VAGUS NERVE STIMULATION
  • 6.2. DEEP BRAIN STIMULATION
    • 6.2.1. MOVEMENT DISORDERS
    • 6.2.2. EPILEPSY
  • 6.3. ACCELEROMETRY
  • 6.4. RESPONSIVE NEUROSTIMULATION

7. MARKET BY DETECTION & PREDICTION DEVICES TYPE

  • 7.1. ELECTROENCEPHALOGRAM
  • 7.2. INTRACRANIAL EEG
  • 7.3. SURFACE ELECTROMYOGRAPHY
  • 7.4. ELECTROCARDIOGRAPHY
  • 7.5. VIDEO DETECTION SYSTEMS
  • 7.6. ELECTRODERMAL ACTIVITY
  • 7.7. IMPLANTED ADVISORY SYSTEMS
  • 7.8. OTHER DETECTION & PREDICTION DEVICE TYPES

8. MARKET BY END-USER

  • 8.1. HOSPITALS & CLINICS
  • 8.2. NEUROLOGY CENTERS
  • 8.3. HOME CARE SETTINGS
  • 8.4. OTHER END-USERS

9. GEOGRAPHICAL ANALYSIS

  • 9.1. EUROPE
    • 9.1.1. MARKET SIZE & ESTIMATES
    • 9.1.2. KEY GROWTH ENABLERS
    • 9.1.3. KEY CHALLENGES
    • 9.1.4. KEY PLAYERS
    • 9.1.5. COUNTRY ANALYSIS
      • 9.1.5.1. UNITED KINGDOM
      • 9.1.5.2. GERMANY
      • 9.1.5.3. FRANCE
      • 9.1.5.4. ITALY
      • 9.1.5.5. SPAIN
      • 9.1.5.6. NORDIC COUNTRIES
      • 9.1.5.7. REST OF EUROPE

10. COMPETITIVE LANDSCAPE

  • 10.1. KEY STRATEGIC DEVELOPMENTS
    • 10.1.1. ACQUISITIONS
    • 10.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
    • 10.1.3. PARTNERSHIPS
  • 10.2. COMPANY PROFILES
    • 10.2.1. BOSTON SCIENTIFIC CORPORATION
    • 10.2.2. CADWELL INDUSTRIES INC
    • 10.2.3. COMPUMEDICS LIMITED
    • 10.2.4. DRAGERWERK AG & CO KGAA
    • 10.2.5. EMPATICA INC
    • 10.2.6. KONINKLIJKE PHILIPS NV
    • 10.2.7. LIVANOVA PLC
    • 10.2.8. MEDTRONIC PLC
    • 10.2.9. NATUS MEDICAL INCORPORATED
    • 10.2.10. NEUROPACE INC
    • 10.2.11. NEUROSOFT
    • 10.2.12. NIHON KOHDEN CORPORATION
    • 10.2.13. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO LTD
Product Code: 48681

LIST OF TABLES

  • TABLE 1: EUROPE MARKET SNAPSHOT - EPILEPSY DEVICES
  • TABLE 2: EXAMPLES OF ANTIEPILEPTIC DRUGS FOR THE ELDERLY AND THEIR ADVANTAGES
  • TABLE 3: EXAMPLES OF MOBILE EEG DEVICES
  • TABLE 4: REGULATORY FRAMEWORK
  • TABLE 5: EUROPE EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 6: EUROPE EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 7: EUROPE EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 8: EUROPE EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 9: EUROPE EPILEPSY DEVICES MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 10: EUROPE EPILEPSY DEVICES MARKET, BY TECHNOLOGY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 11: EUROPE EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 12: EUROPE EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 13: EUROPE EPILEPSY DEVICES MARKET, BY DETECTION & PREDICTION DEVICES TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 14: EUROPE EPILEPSY DEVICES MARKET, BY DETECTION & PREDICTION DEVICES TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 15: EUROPE EPILEPSY DEVICES MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 16: EUROPE EPILEPSY DEVICES MARKET, BY END-USER, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 17: EUROPE EPILEPSY DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 18: EUROPE EPILEPSY DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 19: LEADING PLAYERS OPERATING IN EUROPE EPILEPSY DEVICES MARKET
  • TABLE 20: LIST OF ACQUISITIONS
  • TABLE 21: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
  • TABLE 22: LIST OF PARTNERSHIPS

LIST OF FIGURES

  • FIGURE 1: KEY MARKET TRENDS
  • FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: VALUE CHAIN ANALYSIS
  • FIGURE 6: KEY BUYING CRITERIA
  • FIGURE 7: EUROPE EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY PRODUCT TYPE, IN 2021
  • FIGURE 8: EUROPE EPILEPSY DEVICES MARKET, BY CONVENTIONAL DEVICES, 2022-2030 (IN $ MILLION)
  • FIGURE 9: EUROPE EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, 2022-2030 (IN $ MILLION)
  • FIGURE 10: EUROPE EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY WEARABLE DEVICES, IN 2021
  • FIGURE 11: EUROPE EPILEPSY DEVICES MARKET, BY WATCHES, 2022-2030 (IN $ MILLION)
  • FIGURE 12: EUROPE EPILEPSY DEVICES MARKET, BY BRACELETS, 2022-2030 (IN $ MILLION)
  • FIGURE 13: EUROPE EPILEPSY DEVICES MARKET, BY CAMERA DEVICES, 2022-2030 (IN $ MILLION)
  • FIGURE 14: EUROPE EPILEPSY DEVICES MARKET, BY MATTRESS DEVICES, 2022-2030 (IN $ MILLION)
  • FIGURE 15: EUROPE EPILEPSY DEVICES MARKET, BY ANTI-SUFFOCATION PILLOWS, 2022-2030 (IN $ MILLION)
  • FIGURE 16: EUROPE EPILEPSY DEVICES MARKET, BY OTHER WEARABLE DEVICES, 2022-2030 (IN $ MILLION)
  • FIGURE 17: EUROPE EPILEPSY DEVICES MARKET, BY IMPLANTABLE DEVICES, 2022-2030 (IN $ MILLION)
  • FIGURE 18: EUROPE EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY TECHNOLOGY, IN 2021
  • FIGURE 19: EUROPE EPILEPSY DEVICES MARKET, BY VAGUS NERVE STIMULATION, 2022-2030 (IN $ MILLION)
  • FIGURE 20: EUROPE EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2022-2030 (IN $ MILLION)
  • FIGURE 21: EUROPE EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY DEEP BRAIN STIMULATION, IN 2021
  • FIGURE 22: EUROPE EPILEPSY DEVICES MARKET, BY MOVEMENT DISORDERS, 2022-2030 (IN $ MILLION)
  • FIGURE 23: EUROPE EPILEPSY DEVICES MARKET, BY EPILEPSY, 2022-2030 (IN $ MILLION)
  • FIGURE 24: EUROPE EPILEPSY DEVICES MARKET, BY ACCELEROMETRY, 2022-2030 (IN $ MILLION)
  • FIGURE 25: EUROPE EPILEPSY DEVICES MARKET, BY RESPONSIVE NEUROSTIMULATION, 2022-2030 (IN $ MILLION)
  • FIGURE 26: EUROPE EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY DETECTION & PREDICTION DEVICES TYPE, IN 2021
  • FIGURE 27: EUROPE EPILEPSY DEVICES MARKET, BY ELECTROENCEPHALOGRAM, 2022-2030 (IN $ MILLION)
  • FIGURE 28: EUROPE EPILEPSY DEVICES MARKET, BY INTRACRANIAL EEG, 2022-2030 (IN $ MILLION)
  • FIGURE 29: EUROPE EPILEPSY DEVICES MARKET, BY SURFACE ELECTROMYOGRAPHY, 2022-2030 (IN $ MILLION)
  • FIGURE 30: EUROPE EPILEPSY DEVICES MARKET, BY ELECTROCARDIOGRAPHY, 2022-2030 (IN $ MILLION)
  • FIGURE 31: EUROPE EPILEPSY DEVICES MARKET, BY VIDEO DETECTION SYSTEMS, 2022-2030 (IN $ MILLION)
  • FIGURE 32: EUROPE EPILEPSY DEVICES MARKET, BY ELECTRODERMAL ACTIVITY, 2022-2030 (IN $ MILLION)
  • FIGURE 33: EUROPE EPILEPSY DEVICES MARKET, BY IMPLANTED ADVISORY SYSTEMS, 2022-2030 (IN $ MILLION)
  • FIGURE 34: EUROPE EPILEPSY DEVICES MARKET, BY OTHER DETECTION & PREDICTION DEVICES TYPES, 2022-2030 (IN $ MILLION)
  • FIGURE 35: EUROPE EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY END-USER, IN 2021
  • FIGURE 36: EUROPE EPILEPSY DEVICES MARKET, BY HOSPITALS & CLINICS, 2022-2030 (IN $ MILLION)
  • FIGURE 37: EUROPE EPILEPSY DEVICES MARKET, BY NEUROLOGY CENTERS, 2022-2030 (IN $ MILLION)
  • FIGURE 38: EUROPE EPILEPSY DEVICES MARKET, BY HOME CARE SETTINGS, 2022-2030 (IN $ MILLION)
  • FIGURE 39: EUROPE EPILEPSY DEVICES MARKET, BY OTHER END-USERS, 2022-2030 (IN $ MILLION)
  • FIGURE 40: EUROPE EPILEPSY DEVICES MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
  • FIGURE 41: UNITED KINGDOM EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 42: GERMANY EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 43: FRANCE EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 44: ITALY EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 45: SPAIN EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 46: NORDIC COUNTRIES EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 47: REST OF EUROPE EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!